16 results
8-K
EX-10.2
ENVB
Enveric Biosciences Inc
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case
8-K
EX-10.1
ENVB
Enveric Biosciences Inc
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
8-K
EX-1.1
j438 mwm118y2z
15 Feb 22
Enveric Biosciences Announces Proposed Public Offering
11:07am
424B3
mya rla29l
6 Aug 21
Prospectus supplement
4:31pm
8-K
EX-10.1
aspk8lbkcwbx58cj2d
11 Feb 21
Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering
4:01pm
8-K
EX-10.1
5p5xlhjg
12 Jan 21
Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering
9:10am
8-K
EX-10.1
9xu8lsu ldse433fyxyx
3 Aug 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
7kt w49om3vztmdoogm
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am
8-K
EX-10.1
4ts9ua
25 Nov 19
Entry into a Material Definitive Agreement
7:28am
- Prev
- 1
- Next